Here are relevant reports on : personalized-ai-assistants-market

• Asia Pacific Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA), Application (Diagnostics, Personalized Medicine), & End User (CROs) - Forecast to 2030

  The Asia Pacific nucleic acid isolation and purification market, valued at USD1.49 billion in 2024, stood at USD1.61 billion in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2025 to 2030, culminating in a forecasted valuation of USD2.65 billion by the end of the period. The Asia Pacific market for nucleic acid isolation and purification is expanding due to the increasing number of molecular tests and the scale-up of PCR and NGS across the region.

  • Published: September 2026
  • Price: $ 4950
  • TOC Available:

• Personalized Nutrition Market by Product (Products, Services, Digital Tools), Application (General Lifestyle, Beauty, Skin & Longevity, Weight Management & Metabolic Health), End-use, Personalization Basis, Type, & Region - Global Forecast to 2030

  The personalized nutrition market is estimated to be USD 15.79 billion in 2025 and is projected to reach USD 30.94 billion by 2030, at a CAGR of 14.4% from 2025 to 2030. The report profiles key players such as Abbott (US), Nestlé Health Science (Switzerland), Medtronic (Ireland), 23andMe (US), Prenetics (Hong Kong), ZOE (UK), Viome (US), InsideTracker (USA), Nutrigenomix (Canada), Rootine (US), Sun Genomics (US), etc.

  • Published: October 2025
  • Price: $ 4950
  • TOC Available:

• Prescriptive Analytics Market by Component, Application (Customer Retention and Engagement and Personalized Recommendation), Deployment Mode, Organization Size, Vertical, Capability, and Region (2022 - 2026)

  The prescriptive analytics market size is projected to reach USD 14.3 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 24.0% during the forecast period. The major vendors in the global prescriptive analytics market include IBM (US), Microsoft (US), Salesforce (US), SAP (Germany), SAS Institute (US), Talend (US), FICO (US), Ayata (US), Altair (US), Alteryx (US), TIBCO (US), Sisense(US) Happiest Minds (India), Zebra (England), Infor (US), RapidMiner (US), Logi Analytics (US), Qlik (US), River Logic (US), Frontline Systems (US), Netformx (US), Mitek Analytics (France), and Panorat.IO (US).

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• Europe Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, mRNA), Application (Diagnostics, Personalized Medicine), End User (CROs) - Forecast to 2030

  The Europe nucleic acid isolation and purification market, valued at USD1.52 billion in 2024, stood at USD1.61 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of USD2.41 billion by the end of the period. The growth of the Europe nucleic acid isolation and purification market is strongly linked to the region’s high volume of molecular tests and the steady adoption of PCR- and NGS-based workflows.

  • Published: September 2026
  • Price: $ 4950
  • TOC Available:

• Molecular Cytogenetics Market by Product (Kits, Reagents, Probes, Instrument, Software, Services), Technique (FISH, CISH, Comparative Genomic Hybridization [Array-based, Standard]), Application (Cancer, Personalized Medicine) - Global Forecast to 2030

  The global molecular cytogenetics market, valued at US$0.97 billion in 2024, stood at US$1.02 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2024 to 2030, culminating in a forecasted valuation of US$1.43 billion by the end of the period. The market growth is fueled by increasing incidence of cancer & genetic disorders and rising usage of molecular cytogenetics in clinical pathology testing.

  • Published: October 2025
  • Price: $ 4950
  • TOC Available:

• Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028

  The global pharmacogenomics market, valued at US$3.3 billion in 2022, stood at US$3.5 billion in 2023 and is projected to advance at a resilient CAGR of 10.6% from 2023 to 2028, culminating in a forecasted valuation of US$5.8 billion by the end of the period. The increasing focus on the translational approach to optimize drug development processes, increasing collaborations and partnerships between key players and research institutes, and rising incidence of cancer are the major driving factors of the pharmacogenomics market.

  • Published: February 2024
  • Price: $ 4950
  • TOC Available:

• Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029

  The global human organoids market, valued at US$1.07 billion in 2023, stood at US$1.19 billion in 2024 and is projected to advance at a resilient CAGR of 14.4% from 2024 to 2029, culminating in a forecasted valuation of US$2.33 billion by the end of the period. The main factor driving this market is the rising demand for organoids in drug testing, as they provide more reliable results than conventional 2D cell cultures.

  • Published: December 2024
  • Price: $ 4950
  • TOC Available:

• AI Studio Market by Software (Application Development (MLOps, DataOps, DevOps, Chatbot), AI Model Management (Monitoring, Governance & Compliance), Versioning & Automation, AutoML, Reporting & Analytics, Data Annotation & Labeling) - Global Forecast to 2029

  The AI Studio market is projected to reach USD 32.7 billion by 2029, at a compound annual growth rate (CAGR) of 38.4% during the forecast period. Some major players in the AI Studio market include Microsoft (US), IBM (US), Google (US), AWS (US), Vonage (US), Sprinklr (US), Blaize (US), DataRobot (US), Altair (US), C3 AI (US), HP (US), SparkCognition (US), Icertis (US), Intel (US), DeepBrain AI (US), AgileEngine (US), Expert.ai (Italy), Ushur (US), Avenue Code (US), Qubika (US), Anthropic (US), Evolve IP (US), Databricks (US), Brillio (US), Appy Pie (US), Conju (Canada), Bricabrac AI (US), Donakosy (UK), Bappfy AI (France), DeepOpinion (Austria), Orkes (US), and Branchbob AI (Germany).

  • Published: May 2024
  • Price: $ 4950
  • TOC Available:

• AI Detector Market by Offering (Platform, API/SDKs), Detection Modality (AI Generated Text, Image, Video, Voice, Code), Application (Academic Integrity, Plagiarism Detection, Deepfake Detection, Content Authenticity Assessment) - Global Forecast to 2030

  The AI detector market is undergoing rapid expansion, with estimates projecting a substantial market surge from approximately USD 0.58 billion in 2025 to USD 2.06 billion by 2030, at a CAGR of 28.8%. Some major players in the AI detector market include: GPTZero (US), Originality.AI (Canada), Copyleaks (US), Turnitin (US), Writer.com (US), Smodin (US), Hive Moderation (US), Truepic (US), BrandWell AI (US), QuillBot (US), Scribbr (Netherlands), Grammarly (US), Surfer (Poland), Winston AI (Canada), AI Detector Pro (AIDP) (US), Illuminarty (US), DuckDuckGoose (Netherlands), Crossplag (US), ZeroGPT (US), Sapling.ai (US), TraceGPT (PlagiarismCheck.org) (UK), Pangram Labs (US), Compilatio (France), Scalenut (US), Quetext (US), Sightengine (France), Sensity (Netherlands), Reality Defender (US), Attestiv (US), AI or Not (US), Facia.ai (UK), Resemble AI (US), Pindrop (US), Blackbrid.AI (US), and Perfios (India).

  • Published: September 2025
  • Price: $ 4950
  • TOC Available:

• Stroke AI Market by Offering (Software, [AI], Services), Classification (ICD, CPT, HCPCS), Specialty (Surgical, Radiology), Function (Code, Assignment, Reimbursement, Analytics, Denial, Audit), End User (Hospital, ASC, Payers) - Global Forecast to 2030

  The global stroke AI market, valued at US$0.22 billion in 2024, stood at US$0.32 billion in 2025 and is projected to advance at a resilient CAGR of 38.4% from 2025 to 2030, culminating in a forecasted valuation of US$1.60 billion by the end of the period. The stroke AI market is growing steadily, driven by the need for faster stroke detection, improved clinical decision-making, and reduced time-to-treatment. Increasing adoption of AI-enabled CT and MRI analysis for stroke triage, coupled with rising stroke incidence, aging populations, and hospital digitization, is accelerating demand.

  • Published: October 2026
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS
• NEXT
• LAST

Records 31 to 40 of 50